Intellectual Property and Open Movements (IP&OM)

Issues and developments related to Intellectual Property (e.g. Copyright, Fair Use, Patents, Trademarks, Trade Secrets) and Open Movements (e.g. Open Access, Open Data, Open Educational Resources (OER)), examined in the "Intellectual Property and Open Movements" and "Ethics of Data, Information, and Emerging Technologies" graduate courses I teach at the University of Pittsburgh School of Computing and Information. -- Kip Currier, PhD, JD

Showing posts with label Arbutus Biopharma. Show all posts

Tuesday, March 1, 2022

Moderna faces new lawsuit over lucrative coronavirus vaccine; The Washington Post, February 28, 2022

Yasmeen Abutaleb and Christopher Rowland, The Washington Post; Moderna faces new lawsuit over lucrative coronavirus vaccine

"Moderna faces yet another patent challenge over its coronavirus vaccine after Arbutus Biopharma and Genevant Sciences, both small biotechnology companies, filed a lawsuit on Monday alleging Moderna hijacked its technology to develop the multibillion-dollar vaccine."